Medicare

Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer

Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public…

2 hours ago

Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer

Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public…

2 hours ago

ID.me Announces Contract with CMS to Advance Access, Security, and User Experience on Medicare.gov

MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare…

2 hours ago

ID.me Announces Contract with CMS to Advance Access, Security, and User Experience on Medicare.gov

MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare…

2 hours ago

The Great American Elderverse™ Comes to Texas

Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower…

2 hours ago

The Great American Elderverse™ Comes to Texas

Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower…

2 hours ago

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for…

5 hours ago

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for…

5 hours ago

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

SUNNYVALE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for…

5 hours ago

Healthcare Payer IT in 2026: Digital Prior Authorization, Enforceable Transparency, and Outcomes-Driven Platforms Spark a New Acquisition Race

CMS compliance deadlines and heightened cybersecurity expectations are accelerating payer interoperability and utilization management modernization while shifting vendor selection toward…

17 hours ago